Cover Image

Horseshoe kidney with concurrent mesangial proliferative IgA nephropathy：one case report

Saved in:

Bibliographic Details
Main Authors:	Huang Tan (Author), Sheng-jun Liu (Author), Kan Liao (Author), Yuan Gao (Author), Jiang-hua Sun (Author), Chen-ling Liu (Author)
Format:	Book
Published:	Editorial Department of Journal of Clinical Nephrology, 2024-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy
by: Junjun Zhang, et al.
Published: (2021)

IgA Enhances IGF-1 Mitogenic Activity Via Receptor Modulation in Glomerular Mesangial Cells: Implications for IgA-Induced Nephropathy
by: Amal Al-Eisa, et al.
Published: (2017)

Concurrent Anti-glomerular Basement Membrane Nephritis and IgA Nephropathy
by: Kwang-Sun Suh, et al.
Published: (2019)

Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells
by: T. J. F. Reterink, et al.
Published: (1996)

Sulodexide in IgA nephropathy
Published: (2013)

Clinical significance of IgA nephropathy with hyperuricemia
by: Han Zhou, et al.
Published: (2024)

Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion
by: Xiaodong Zhu, et al.
Published: (2022)

Treatment of rapidly progressive IgA nephropathy with glucocorticoid plus telitacicept: one case report
by: Jia-xin Huang, et al.
Published: (2024)

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
by: Kai Zhang, et al.
Published: (2019)

Clinicopathologic characteristics and outcomes of IgA nephropathy patients with different proportions of crescent
by: Chun-hua Liu, et al.
Published: (2024)

Research advances Progress in the pathogenesis of IgA nephropathy
by: Fei-fei Wang, et al.
Published: (2024)

Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients
by: Petr Kosztyu, et al.
Published: (2018)

Turner syndrome complicated with mesangial proliferative nephritis: one case report with a literature review
by: Min Lu, et al.
Published: (2024)

Management of IgA Nephropathy in Pediatric Patients
by: Sophie Schroda, et al.
Published: (2022)

Treatment and outcome of IgA nephropathy in children from one single center experience
by: Youying Mao, et al.
Published: (2023)

Role of abnormal glycosylated IgA1 and interstitial transformation of glomerular endothelial cells in the development and progression of IgA nephropathy
by: Wanyu Jia, et al.
Published: (2023)

Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children
by: Yan Lv, et al.
Published: (2023)

IgA nephropathy combined with thin basement membrane nephropathy in children
Published: (2013)

In vivo components analysis of Shenhua tablets active in IgA nephropathy
by: Huiqiang Liu, et al.
Published: (2024)

Immune Characteristics of IgA Nephropathy With Minimal Change Disease
by: Huixian Li, et al.
Published: (2021)

Clinicopathological Features and Outcomes of IgA Nephropathy with Hematuria and/or Minimal Proteinuria
by: Min Tan, et al.
Published: (2015)

New Insights into the Pathogenesis and Therapies of IgA Nephropathy
Published: (2022)

The case of nutcracker phenomenon associated with IgA nephropathy
by: Medin Danilo V., et al.
Published: (2021)

Diagnosis and treatment of patients with IgA nephropathy in Japan
by: Yasuhiko Tomino
Published: (2016)

Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-κB signaling pathway
by: Wencheng Xu, et al.
Published: (2023)

Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2020)

Gene Expression Profile in Experimental Mesangial Proliferative Glomerulonephritis
by: Yasukatsu Izumi, et al.
Published: (2004)

Prognosis of IgA Nephropathy with Stages 3b-5 CKD
by: Zhanfei Wu, et al.
Published: (2024)

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study
by: Mian-Na Luo, et al.
Published: (2023)

Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria
by: Ding Chen, et al.
Published: (2018)

Chylopericardium in a child with IgA nephropathy: a case report
by: Yu-lin Kang, et al.
Published: (2018)

One type of duplex appendix: horseshoe appendix
by: Liu J, et al.
Published: (2018)

Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy
by: Caiqiong Liu, et al.
Published: (2021)

Corticosteroid therapy in IgA Nephropathy: A friend or foe?
by: Dana Kim, et al.
Published: (2023)

Therapeutic Effects of FK506 on IgA Nephropathy Rat
by: Linting Wei, et al.
Published: (2017)

Exacerbation of IgA nephropathy in a patient receiving dupilumab
by: Masako Yamamoto, MD, et al.
Published: (2022)

An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
by: Xin Huang, et al.
Published: (2021)

Blood and urine biomarkers of disease progression in IgA nephropathy
by: Zhi-Yu Duan, et al.
Published: (2024)

Proceedings of 16th International Symposium on IgA Nephropathy
Published: (2021)

The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy
by: Jingying Zhao, et al.
Published: (2021)